Stockreport

Digital health startup Transcarent takes Accolade private in $621 million deal [CNBC]

Teladoc Health, Inc.  (TDOC) 
Last teladoc health, inc. earnings: 4/29 04:05 pm Check Earnings Report
US:NYSE Investor Relations: ir.teladoc.com/investors/default.aspx
PDF Accolade shareholders received $7.03 per share in cash, and the company will no longer be listed on the Nasdaq. Transcarent CEO Glen Tullman previously led Livongo, w [Read more]